| Advances in treatment formulations for acute myeloid leukemia T Briot, E Roger, S Thépot, F Lagarce Drug discovery today 23 (12), 1936-1949, 2018 | 52 | 2018 |
| Paving the way for phage therapy using novel drug delivery approaches T Briot, C Kolenda, T Ferry, M Medina, F Laurent, G Leboucher, F Pirot, ... Journal of Controlled Release 347, 414-424, 2022 | 25 | 2022 |
| Past and future of phage therapy and phage-derived proteins in patients with bone and joint infection T Ferry, C Kolenda, T Briot, A Souche, S Lustig, J Josse, C Batailler, ... Viruses 13 (12), 2414, 2021 | 23 | 2021 |
| Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia T Briot, E Roger, N Lautram, A Verger, A Clavreul, F Lagarce International journal of nanomedicine, 8427-8442, 2017 | 21 | 2017 |
| Bacterial keratitis treated by strengthened antibiotic eye drops: An 18 months review of clinical cases and antibiotic susceptibilities J Saillard, L Spiesser-Robelet, P Gohier, T Briot Annales Pharmaceutiques Françaises 76 (2), 107-113, 2018 | 19 | 2018 |
| Implementation of a complex bone and joint infection phage therapy centre in France: lessons to be learned after 4 years' experience T Ferry, C Kolenda, T Briot, S Lustig, G Leboucher, F Laurent, F Valour, ... Clinical Microbiology and Infection 28 (1), 145-146, 2022 | 16 | 2022 |
| Design and stability study of a paediatric oral solution of methotrexate 2 mg/ml S Vrignaud, T Briot, A Launay, M Kempf, F Lagarce International Journal of Pharmaceutics 487 (1-2), 270-273, 2015 | 11 | 2015 |
| Stability of micafungin sodium solutions at different concentrations in glass bottles and syringes T Briot, S Vrignaud, F Lagarce International Journal of Pharmaceutics 492 (1-2), 137-140, 2015 | 10 | 2015 |
| Safety of tedizolid as suppressive antimicrobial therapy for patients with complex implant-associated bone and joint infection due to multidrug-resistant Gram-positive … T Ferry, A Conrad, E Senneville, S Roux, C Dupieux-Chabert, A Dinh, ... Open Forum Infectious Diseases 8 (7), ofab351, 2021 | 7 | 2021 |
| Di-O-lauroyl-decitabine-lipid nanocapsules: toward extending decitabine activity T Briot, E Roger, N Bou Haidar, J Bejaud, N Lautram, C Guillet, S Thépot, ... International journal of nanomedicine, 2091-2102, 2019 | 6 | 2019 |
| Blue dye embolization of renal tumor: A new technique to improve tumor localization during laparoscopic partial nephrectomy A Bouvier, L Besnier, A Paisant, T Briot, T Hebert, V Daniel, L Beydon, ... Journal of Laparoendoscopic & Advanced Surgical Techniques 30 (3), 299-303, 2020 | 5 | 2020 |
| Stability of reconstituted and diluted mitomycin C solutions in polypropylene syringes and glass vials T Briot, C Truffaut, L Le Quay, A Lebreton, F Lagarce Pharmaceutical Technology in Hospital Pharmacy 1 (2), 83-89, 2016 | 3 | 2016 |
| Les virus au service de la santé: les bactériophages N Benech, L Chaffringeon, T Briot, C Kolenda, F Pirot, F Laurent, T Ferry médecine/sciences 38 (12), 1043-1051, 2022 | 2 | 2022 |
| Stability of a 50 mg/mL ceftazidime eye-drops formulation E Gautier, J Saillard, C Deshayes, S Vrignaud, F Lagarce, T Briot Pharmaceutical Technology in Hospital Pharmacy 3 (4), 219-226, 2018 | 2 | 2018 |
| Développement et validation d’une méthode de dosage des traces de détergents inactivants totaux du prion T Briot, A Robelet, N Morin, J Riou, B Lelièvre, AV Lebelle-Dehaut Annales Pharmaceutiques Françaises 74 (4), 317-325, 2016 | 1 | 2016 |
| Real-time Monitoring by Interferometric Light Microscopy of Phage Suspensions for Personalised Phage Therapy B Lapras, C Merienne, E Eynaud, L Usseglio, C Marchand, M Medina, ... | | 2024 |
| Clinical remission after faecal microbiota transplantation in transplanted recipients with refractory chronic Norovirus infections: a retrospective case series S Soueges, V Cheynet, T Briot, CM du Vignaux, N Benech, F Ader Clinical Microbiology and Infection, 2024 | | 2024 |
| Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case … N Benech, N Cassir, T Galperine, L Alric, J Scanzi, H Sokol, C Melchior, ... Gastroenterology, 2024 | | 2024 |
| 3PC-041 Public production of therapeutic bacteriophages C Merienne, B Lapras, C Kolenda, M Medina, C Marchand, M Bonhomme, ... European Journal of Hospital Pharmacy 31 (Suppl 1), A48-A48, 2024 | | 2024 |
| 3PC-039 Early de-risking of the stability of a personalised, sterile bacteriophage suspension on the basis of advanced kinetic modelling C Merienne, B Lapras, C Marchand, M Medina, T Briot, C Paillet, ... European Journal of Hospital Pharmacy 31 (Suppl 1), A47-A47, 2024 | | 2024 |
